Thalidomide and lenalidomide for the treatment of refractory dermatologic conditions.
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Zachary
Z
Nahmias
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Medicine, Grand Strand Regional Medical Center, Myrtle Beach, South Carolina.
Vinod E
VE
Nambudiri
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: rvleugels@partners.org.
Ruth Ann
RA
Vleugels
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D019233:Retreatment; D012871:Skin Diseases / Q000188:drug therapy*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D007155:Immunologic Factors; D013792:Thalidomide; D000077269:Lenalidomide